An ‘innocent bystander’ in the booming biotech investor world is writing a blank check for $100M. Who’s going to cash it?

Srini Akkaraju

Srini Akkaraju’s LinkedIn profile describes his work as a “biotech investor (aka innocent bystander)” with tongue-in-cheek modesty. But he’s been deeply steeped in the ways of venture investing since leaving a BD job at Genentech in 2001, following a career path that wound through…

Click to view original post